High Prognostic Value of <sup>18</sup>F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation

2014183 citationsJournal Articlebronze Open Access

Authors

Haïfa Bahri · Centre Eugène Marquis

Laurence Lenoir · Centre Eugène Marquis

Julien Edeline · Université de Rennes

Houda Leghzali · Centre Eugène Marquis

Anne Devillers · Centre Eugène Marquis

Jean‐Luc Raoul · Institut Paoli-Calmettes

Marc Cuggia ·

Abstract

Overall, (18)F-FDG PET appears to be of major importance in the prognostic evaluation of metastatic GEPNET. A positive (18)F-FDG PET with an SUV ratio (T/NT) of 2.5 or greater was a poor prognostic factor, with a 4-y survival rate of 0%. A positive SRS does not eliminate the need for performing (18)F-FDG PET, which is of greater prognostic utility.

Topics & Keywords

Neuroendocrine Tumor Research Advances Lung Cancer Research Studies Pancreatic and Hepatic Oncology Research

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Journal of Nuclear Medicine

Volume 55, Issue 11, pp. 1786-1790

DOI: 10.2967/jnumed.114.144386

Field-Weighted Citation Impact: 8.58